IDH1 and epilepsy: IDH mutations may contribute to postoperative epilepsy by producing D-2-hydroxyglutarate (D2HG), a structural analog of glutamate that mimics excitatory neurotransmitter activity at NMDA receptors, leading to hyperactive neuronal circuits and increased susceptibility to seizures (63).